Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine
Joaquín González, Matías Cavelli, Santiago Castro-Zaballa, Alejandra Mondino, Adriano B. L. Tort, Nicolás Rubido, Ignacio Carrera, Pablo Torterolo
bioRxiv (Cold Spring Harbor Laboratory) June 29, 2020 preprint DOI: 10.1101/2020.06.25.172304 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study |
|---|---|
| Population | Rats |
| Intervention | Ibogaine |
| Topics | Ibogaine |
| Keywords | Wakefulness Dream Electrophysiology Electroencephalography |
| Citations | 5 |
| Key findings | Ibogaine induces gamma oscillations with larger power but reduced coherence and complexity, showing clear REM sleep traits within the gamma frequency band during wakefulness. |
Abstract
Abstract Ibogaine is a psychedelic alkaloid that has attracted scientific interest because of its important antiaddictive properties evidenced in observational studies in humans, and in models for substance-use-disorders in rodents. Its subjective effect has been described as intense vivid dream-like experiences occurring while awake; hence, ibogaine is often referred to as an oneirogenic psychedelic. While this unique dream-like profile has been hypothesized to aid the antiaddictive effects in the past, the electrophysiological signatures of the ibogaine psychedelic state remain unknown. In our previous work, we showed in rats that ibogaine administration promotes a waking state with abnormal motor behavior, accompanied by a decrease in NREM and REM sleep. Here, we performed an in-depth analysis of the intracranial electroencephalogram during “ibogaine wakefulness”. Ibogaine induced gamma oscillations with larger power than control levels but less coherent and less complex; i.e., this state shows clear REM sleep traits within the gamma frequency band. Thus, our results provide novel biological evidence for the association between the psychedelic state and REM sleep, and an empirical basis for the oneirogenic conjecture of ibogaine.